Role of cyclooxygenase-2 in lipopolysaccharide-induced hyperalgesia in formalin test

Indian Journal of Experimental Biology

Volumn 43, Issue 1, 2005, Pages 53-60

  Padi, Satyanarayana S V ^a   Kulkarni, Shrinivas K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

Cyclooxygenase isoforms; Formalin test; Hyperalgesia; Lipopolysaccharide

Indexed keywords

BIOASSAY; ENZYMES; FORMALDEHYDE; POLYSACCHARIDES;

CYCLOOXYGENASE (COX); HYPERALGESIA; LIPOPOLYSACCHARIDES (LPS); SALINE PRETREATMENT;

ENZYME KINETICS;

CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; DEXAMETHASONE; ISOENZYME; ISOXAZOLE DERIVATIVE; KETOROLAC; LIPOPOLYSACCHARIDE; PARECOXIB; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE INHIBITOR;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; ENZYMOLOGY; FEMALE; HYPERALGESIA; MALE; METABOLISM; MOUSE; PAIN ASSESSMENT; SALMONELLA TYPHIMURIUM;

ANIMALS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DEXAMETHASONE; DISEASE MODELS, ANIMAL; FEMALE; HYPERALGESIA; ISOENZYMES; ISOXAZOLES; KETOROLAC; LIPOPOLYSACCHARIDES; MALE; MICE; PAIN MEASUREMENT; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SALMONELLA TYPHIMURIUM;

ANIMALIA;

EID: 11444254227     PISSN: 00195189     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Malmberg A B & Yaksh T L, Antinociceptive actions of spinal non-steroidal anti-inflammatory agents on the formalin test in the rat, J Pharmacol Exp Ther, 263 (1992) 136.
2. Willingale H L, Gardiner N J, McLymont N, Giblet S & Grubb B D, Prostanoids synthesized by cyclooxygenase isoforms in the rat spinal cord and their contribution to the development of neuronal hyperexcitability, Br J Pharmacol, 122 (1997) 1593.
3. Kulkarni S K, Jain N K & Singh A, Cyclooxygenase isoenzymes and newer therapeutic potential for selective COX-2 inhibition, Methods Find Exp Clin Pharmacol, 22 (2000) 291.
4. Chandrasekharan N V, Dai H, Tarepu Roos K L, Evanson N K, Tomsik J, Elton T S & Simmons D L, COX-3, a cyclooxygenase-1 variant inhibited by acetaminophen and other analgesic/antipyretic drugs: Cloning, structure and expression, Proc Natl Acad Sci USA, 99 (2002) 13926.
5. Bluthe R M, Lestage J, Rees G, Bristow A & Dantzer R, Dual effect of central injection of recombinant rat interleukin-4 on lipopolysaccharide induced sickness behaviour in rats, Neuropsychopharmacology, 26 (2002) 86.
6. Kent R S, Bluthe R M, Kelly K W & Dantzer R, Sickness behaviour as a new target for drug development, Trends Pharamcol Sci, 13 (1992) 24.
7. Watkins L R, Wiertelak E P, Goehler L E, Smith K P, Martin D & Maier S F, Characterization of cytokine-induced hyperalgesia, Brain Res, 654 (1994) 15.
8. Jain N K, Patil C S, Kulkarni S K & Singh A, Modulatory role of nitric oxide and cyclooxygenase pathway in LPS-mediated hyperalgesia, Inflammopharmacology 9 (2002) 373.
9. Hamilton L C & Warner T D, Interactions between inducible isoforms of nitric oxide synthase and cyclooxygenase in vivo: Investigations using the selective inhibitors, 1400W and celecoxib, Br J Pharmacol, 125 (1998) 335.
10. Matsumoto H, Naraba H, Ueno A, Fujiyoshi T, Murakami M, Kudo I & Oh-ishi S, Induction of cyclooxygenase-2 causes an enhancement of writhing response in mice, Eur J Pharmacol, 352 (1998) 47.
11. 2 endotoxin-induced localised inflammatory hyperalgesia, Br J Pharmacol, 121 (1997) 1619.
12. Anjaneyulu M & Chopra K, Reversal of lipopolysaccharide-induced thermal and behavioural hyperalgesia by quercetine, Drug Dev Res, 58 (2003) 248.
13. Jain N K, Patil C S, Kulkarni S K & Singh A, Rofecoxib reversal of lipopolysaccharide-mediated central and peripheral hyperalgesia, Brain Pharmacol, 1 (2001) 73.
14. Samad T A, Moore K A, Sapirstein A, Billet S, Allchome A, Poole S, Bonventre J V & Woolf C J, Interleukin-1beta-mediated induction of COX-2 in the CNS contributes to inflammatory pain hypersensitivity, Nature, 410 (2001) 471.
15. Satyanarayana P S V, Jain N K, Singh S & Kulkarni S K, Effect of selective inhibition of cyclooxygenase-2 on lipopolysaccharide-induced hyperalgesia, Inflammopharmaoology, 12 (2004) 57.
16. Abbott F V & Franklin K B J, Noncompetitive antagonism of morphine analgesia by diazepam in the formalin test, Pharmacol Biochem Behav, 24 (1986) 319.
17. Murray C W, Porreca F & Cowan A, Methodological refinement of the mouse paw formalin test, J Pharmacol Meth, 20 (1988) 175.
18. Abbadie C, Taylor K T, Peterson M A & Basbaum A I, Differential contribution of the two phases of the formalin test to the pattern of c-fos expression in the rat spinal cord: Studies with remifentanil and lidocaine, Pain, 69 (1997) 101.
19. Dirig D M, Konin G P, Isakson P C & Yaksh T L, Effect of spinal cyclooxygenase inhibitors in rat using the formalin test and in vitro prostaglandin E2, Eur J Pharmacol, 331 (1997) 155.
20. Padi S S V, Jain N K, Singh S & Kulkarni S K, Pharmacological profile of parecoxib: A novel, potent injectable selective COX-2 inhibitor, Eur J Pharmacol, 491 (2004) 69.
21. 3 receptor knockout mice, Br J Pharmacol, 133 (2001) 438.
22. Kanaan S A, Saade N E, Hadda J J, Abdelnoor A M, Atweh S F, Jabbur S J & Safeih-Grarbedian B, Endotoxin-induced local inflammation and hyperalgesia in rats and mice: A new model for inflammatory pain, Pain, 66 (1996) 373.
23. Eriksson C, Nobel S, Winblad B & Schultzberg M, Expression of interleukin-1α and β, and interleukin-1 receptor antagonist mRNA in the rat central nervous system after peripheral administration of lipopolysaccharides, Cytokine, 12 (2000) 423.
24. 2 release, Eur J Pharmacol, 166 (1989) 131.
25. Liu S F, Newton R, Evans T W & Barnes P J, Differential regulation of cyclooxygenase-1 and cyclooxygenase-2 gene by lipopolysaccharide treatment in vivo in the rat, Clin Sci, 90 (1996) 301.
26. 2, Biochem Biophys Res Commun, 230 (1997) 110.
27. Marziniak M & Sommer C, Upregulation of cyloxygenase-2 is dependent on tumor necrosis receptor factor 1 and 2 after chronic constriction injury, J Neurol, 247(III). (2000) 125.
28. Stichtenoth D O, Thoren S, Bian H, Peters-Golden M, Jakobsson P- H & Crofford L J, Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells, J Immmunol, 42 (2001) 469.
29. Beiche F, Scheuerer S, Brune K, Geisslinger G & Goppelt-Struebe M, Up-regulation of cyclooxygenase-2 mRNA in the rat spinal cord following peripheral inflammation, FEBS Lett, 390 (1996) 165.
30. 2 I a model of acute arthritis is accompanied by an upregulation of cyclooxygenase-2 in the spinal cord, Neuroscience, 93 (1999) 775.
31. Ma W & Eisenach J C, Cyclooxygenase-2 in the infiltrating inflammatory cells in injured nerve is universally upregulated following various types of peripheral nerve injury, Neuroscience, 121 (2003) 691.
32. Hwang D, Jang B C, Yu G & Biudreau M, Expression of mitogen-inducible cyclooxygenase induced by lipopolysaccharide; mediation through by both mitogen activated protein kinases and NF-kappaB signalling pathways I macrophages, Biochem Pharmacol, 54 (1997) 87.
33. Schuligoi R, Ulcar R, Peskar B A & Amann R, Effect of endotoxin treatment on the expression of cyclooxygenase-2 and prostaglandin synthase in spinal cord, dorsal root ganglia, and skin of rats, Neuroscience, 116 (2003) 1043.
34. Hempel S L, Monick M M & Hunninghake G W, Lipopolysaccharide induces prostaglandin synthase-2 protein and mRNA in human alveolar macrophages and blood monocytes, J Clin Invet, 93 (1994) 391.
35. 2 production, J Pharmacol Exp Ther, 283 (1997) 1069.
36. Calcutt N A, Jorge M C, Yaksh T L & Chaplan S R, Tactile allodynia and formalin hyperalgesia in Streptozocin-diabetic rats: effects of insulin, aldose reductase inhibition and lidocaine, Pain, 68 (1996) 293.
37. Courteix C, Eschalier A & Lavarenne J, Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain, Pain, 53 (1993) 81.
38. LaBuda CJ, Donahue R & Fuchs PN, Enhanced formalin nociceptive responses following L5 nerve ligation in the rat reveals neuropathy-induced inflammatory hyperalgesia, Pain, 94 (2001) 59.
39. Ma W & Eisenach J C Morphological and pharmacological evidence for the role of peripheral prostaglandins in the pathogenesis of neuropathic pain, Eur J Neurosci, 15 (2002) 1037.
40. Pop-Busui R, Marinescu V, Van Huysen C V, Li F, Sullivan K, Greene D A, Larkin D & Stevens M J, Dissection of metabolic, vascular, nerve conduction interrelationships in experimental diabetic neuropathy by cyclooxygenase inhibition and acetyl-1-carnitine administration, Diabetes, 51 (2002) 2619.